A citation-based method for searching scientific literature


List of co-cited articles
401 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
759
19

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
19

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
401
17

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
Masayuki Arakawa, Tomoya Mita, Kosuke Azuma, Chie Ebato, Hiromasa Goto, Takashi Nomiyama, Yoshio Fujitani, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada. Diabetes 2010
355
14

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Kiwon Ban, M Hossein Noyan-Ashraf, Judith Hoefer, Steffen-Sebastian Bolz, Daniel J Drucker, Mansoor Husain. Circulation 2008
734
14

Cardiovascular actions of incretin-based therapies.
John R Ussher, Daniel J Drucker. Circ Res 2014
236
14



Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
Matthew James Armstrong, Piers Gaunt, Guruprasad P Aithal, Darren Barton, Diana Hull, Richard Parker, Jonathan M Hazlehurst, Kathy Guo, George Abouda, Mark A Aldersley,[...]. Lancet 2016
780
10

GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.
Naim Panjwani, Erin E Mulvihill, Christine Longuet, Bernardo Yusta, Jonathan E Campbell, Theodore J Brown, Catherine Streutker, Dianne Holland, Xiemin Cao, Laurie L Baggio,[...]. Endocrinology 2013
226
10

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
10

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
10

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
10

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury.
Hiromasa Goto, Takashi Nomiyama, Tomoya Mita, Eisuke Yasunari, Kosuke Azuma, Koji Komiya, Masayuki Arakawa, Wen Long Jin, Akio Kanazawa, Ryuzo Kawamori,[...]. Biochem Biophys Res Commun 2011
86
8

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
8

Cardiovascular biology of the incretin system.
John R Ussher, Daniel J Drucker. Endocr Rev 2012
365
8

The glucagon-like peptide-1 receptor--or not?
Charles Pyke, Lotte Bjerre Knudsen. Endocrinology 2013
114
8



Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
WuQiang Fan, Toshihiko Yanase, Hidetaka Morinaga, Taijiro Okabe, Masatoshi Nomura, Hiroaki Daitoku, Akiyoshi Fukamizu, Shigeaki Kato, Ryoichi Takayanagi, Hajime Nawata. J Biol Chem 2007
122
7

Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.
Takashi Nomiyama, Takako Kawanami, Shinichiro Irie, Yuriko Hamaguchi, Yuichi Terawaki, Kunitaka Murase, Yoko Tsutsumi, Ryoko Nagaishi, Makito Tanabe, Hidetaka Morinaga,[...]. Diabetes 2014
56
7

Diabetes mellitus, fasting glucose, and risk of cause-specific death.
Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, Emanuele Di Angelantonio, Pei Gao, Nadeem Sarwar, Peter H Whincup, Kenneth J Mukamal, Richard F Gillum, Ingar Holme,[...]. N Engl J Med 2011
7


Pancreatic safety of incretin-based drugs--FDA and EMA assessment.
Amy G Egan, Eberhard Blind, Kristina Dunder, Pieter A de Graeff, B Timothy Hummer, Todd Bourcier, Curtis Rosebraugh. N Engl J Med 2014
325
7


GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.
Mohammad Hossein Noyan-Ashraf, M Abdul Momen, Kiwon Ban, Al-Muktafi Sadi, Yu-Qing Zhou, Ali M Riazi, Laurie L Baggio, R Mark Henkelman, Mansoor Husain, Daniel J Drucker. Diabetes 2009
398
7


Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
Lotte Bjerre Knudsen, Lars Wichmann Madsen, Søren Andersen, Kasper Almholt, Anne S de Boer, Daniel J Drucker, Carsten Gotfredsen, Frederikke Lihme Egerod, Anne Charlotte Hegelund, Helene Jacobsen,[...]. Endocrinology 2010
342
7

Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
Qusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, Thomas A Bowman, Sadeesh K Ramakrishnan, Simon L Abdallah, Lucia Russo, Payal R Patel, Meenakshi K Kaw, Christian K Raphael,[...]. Diabetes 2015
37
10

Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism.
Anthony M DeAngelis, Garrett Heinrich, Tong Dai, Thomas A Bowman, Payal R Patel, Sang Jun Lee, Eun-Gyoung Hong, Dae Young Jung, Anke Assmann, Rohit N Kulkarni,[...]. Diabetes 2008
69
7

CEACAM1 regulates insulin clearance in liver.
Matthew N Poy, Yan Yang, Khadijeh Rezaei, Mats A Fernström, Abraham D Lee, Yoshiaki Kido, Sandra K Erickson, Sonia M Najjar. Nat Genet 2002
179
7

Serotonin regulates pancreatic beta cell mass during pregnancy.
Hail Kim, Yukiko Toyofuku, Francis C Lynn, Eric Chak, Toyoyoshi Uchida, Hiroki Mizukami, Yoshio Fujitani, Ryuzo Kawamori, Takeshi Miyatsuka, Yasuhiro Kosaka,[...]. Nat Med 2010
347
7

Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy.
A Schraenen, K Lemaire, G de Faudeur, N Hendrickx, M Granvik, L Van Lommel, J Mallet, G Vodjdani, P Gilon, N Binart,[...]. Diabetologia 2010
93
7

Serotonin regulates glucose-stimulated insulin secretion from pancreatic β cells during pregnancy.
Mica Ohara-Imaizumi, Hail Kim, Masashi Yoshida, Tomonori Fujiwara, Kyota Aoyagi, Yukiko Toyofuku, Yoko Nakamichi, Chiyono Nishiwaki, Tadashi Okamura, Toyoyoshi Uchida,[...]. Proc Natl Acad Sci U S A 2013
92
7

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.
J Hsieh, C Longuet, C L Baker, B Qin, L M Federico, D J Drucker, K Adeli. Diabetologia 2010
179
7


Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium.
Fiona M Gribble, Frank Reimann. Annu Rev Physiol 2016
233
7

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
744
7

Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.
Liam M McCormick, Stephen P Hoole, Paul A White, Philip A Read, Richard G Axell, Sophie J Clarke, Michael O'Sullivan, Nick E J West, David P Dutka. JACC Cardiovasc Interv 2015
39
10


The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
7



Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.
Kathleen M Dungan, Santiago Tofé Povedano, Thomas Forst, José G González González, Charles Atisso, Whitney Sealls, Jessie L Fahrbach. Lancet 2014
282
7

Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.
John R Ussher, Laurie L Baggio, Jonathan E Campbell, Erin E Mulvihill, Minsuk Kim, M Golam Kabir, Xiemin Cao, Benjamin M Baranek, Doris A Stoffers, Randy J Seeley,[...]. Mol Metab 2014
79
7

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, Hans Erik Bøtker, Won Yong Kim, Anders B Mathiasen, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Peter Clemmensen,[...]. Eur Heart J 2012
380
7


Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.
Hiroshi Yamamoto, Charlotte E Lee, Jacob N Marcus, Todd D Williams, J Michael Overton, Marisol E Lopez, Anthony N Hollenberg, Laurie Baggio, Clifford B Saper, Daniel J Drucker,[...]. J Clin Invest 2002
378
7

Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
Markus Wallner, Ewald Kolesnik, Klemens Ablasser, Mounir Khafaga, Paulina Wakula, Senka Ljubojevic, Eva Maria Thon-Gutschi, Harald Sourij, Martin Kapl, Nicholas J Edmunds,[...]. J Mol Cell Cardiol 2015
30
13

Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Dario Giugliano, Stefano Genovese. Diabetes Care 2013
115
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.